JUBILANT PHARMOVA
Back to Balance Sheet
|
JUBILANT PHARMOVA Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹10,929 Cr | ₹9,830 Cr | ₹8,763 Cr | ₹12,310 Cr | ₹11,319 Cr |
What is the latest Total Liabilities ratio of JUBILANT PHARMOVA ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹10,929 Cr |
Mar2022 | ₹9,830 Cr |
Mar2021 | ₹8,763 Cr |
Mar2020 | ₹12,310 Cr |
Mar2019 | ₹11,319 Cr |
How is Total Liabilities of JUBILANT PHARMOVA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹10,929 Cr | 11.19 | |
Mar2022 | ₹9,830 Cr | 12.17 | |
Mar2021 | ₹8,763 Cr | -28.81 | |
Mar2020 | ₹12,310 Cr | 8.76 | |
Mar2019 | ₹11,319 Cr | - |
Compare Total Liabilities of peers of JUBILANT PHARMOVA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JUBILANT PHARMOVA | ₹10,933.6 Cr | 0.8% | 19.6% | 117.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
JUBILANT PHARMOVA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JUBILANT PHARMOVA | 0.8% |
19.6% |
117.1% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses